Quantitative trait locus analysis for hemostasis and thrombosis.
Susceptibility to thrombosis varies in human populations as well as many in inbred mouse strains. The objective of this study was to characterize the genetic control of thrombotic risk on three chromosomes. Previously, utilizing a tail-bleeding/rebleeding assay as a surrogate of hemostasis and thrombosis function, three mouse chromosome substitution strains (CSS) (B6-Chr5(A/J), Chr11(A/J), Chr17(A/J)) were identified (Hmtb1, Hmtb2, Hmtb3). The tail-bleeding/rebleeding assay is widely used and distinguishes mice with genetic defects in blood clot formation or dissolution. In the present study, quantitative trait locus (QTL) analysis revealed a significant locus for rebleeding (clot stability) time (time between cessation of initial bleeding and start of the second bleeding) on chromosome 5, suggestive loci for bleeding time (time between start of bleeding and cessation of bleeding) also on chromosomes 5, and two suggestive loci for clot stability on chromosome 17 and one on chromosome 11. The three CSS and the parent A/J had elevated clot stability time. There was no interaction of genes on chromosome 11 with genes on chromosome 5 or chromosome 17. On chromosome 17, twenty-three candidate genes were identified in synteny with previously identified loci for thrombotic risk on human chromosome 18. Thus, we have identified new QTLs and candidate genes not previously known to influence thrombotic risk.
Sa
Qila
Q
Department of Molecular Cardiology, Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Cleveland, OH 44195, USA.
Hart
Erika
E
Hill
Annie E
AE
Nadeau
Joseph H
JH
Hoover-Plow
Jane L
JL
D000483:Alleles; D000818:Animals; D033481:Chromosomes, Mammalian / Q000235:genetics; D004262:DNA Restriction Enzymes / Q000378:metabolism; D005819:Genetic Markers; D006487:Hemostasis / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D018895:Microsatellite Repeats / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D040641:Quantitative Trait Loci / Q000235:genetics*; D013927:Thrombosis / Q000235:genetics*
D005819:Genetic Markers; D004262:DNA Restriction Enzymes
Mamm Genome. 2006 Apr;17(4):273-87
16596449
BMJ. 1995 Jan 21;310(6973):170
7833759
BMC Blood Disord. 2006 Oct 05;6:6
17022820
Science. 2004 Apr 16;304(5669):445-8
15031436
Exp Biol Med (Maywood). 2001 May;226(5):409-19
11393168
Thromb Haemost. 2001 Apr;85(4):747-8
11341518
Mamm Genome. 2004 Jun;15(6):482-91
15181540
Mamm Genome. 2001 Dec;12(12):930-2
11707780
Cancer Res. 2007 Mar 15;67(6):2508-16
17363568
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15352-7
8986815
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):161-6
14592847
Blood. 2004 Oct 15;104(8):2339-44
15213102
Mamm Genome. 2003 Nov;14(11):723-32
14722722
Am J Hum Genet. 1998 Aug;63(2):569-76
9683579
Blood. 2003 Jan 1;101(1):163-7
12393556
Nat Genet. 2000 Mar;24(3):221-5
10700173
Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2273-81
16123318
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):597-603
16373612
Blood. 1990 Dec 1;76(11):2258-65
2124152
Annu Rev Med. 1997;48:45-58
9046944
J Med Genet. 2004 May;41(5):321-3
15121766
J Thromb Haemost. 2004 Aug;2(8):1429-35
15304051
J Thromb Haemost. 2004 Sep;2(9):1564-72
15333032
Genetics. 2002 Apr;160(4):1599-608
11973313
Semin Thromb Hemost. 1999;25(3):321-31
10443962
J Thromb Haemost. 2003 Jul;1(7):1381-90
12871271
J Thromb Haemost. 2007 Feb;5(2):329-35
17155961
Nat Genet. 1999 Oct;23(2):237-40
10508525